The Sinovac vaccine has been discontinued, and there are still vaccines available for injection against the new strain in various places
Jimu News reporter Manda
On January 10, a document titled "Suspension of the Performance-Based Salary Plan for the Coronavirus Project" was circulated online, and the payment was made to Beijing Sinovac Biotechnology Co., Ltd., which mentioned that the company's new crown vaccines have all been discontinued and the company currently has no new crown vaccine products for sale. At noon on January 10, a Jimu News reporter called the product consultation hotline of Sinovac Holding Biotechnology Co., Ltd., and the staff confirmed that Sinovac's new crown vaccine had indeed been discontinued, and if the product still needed to be injected, it was necessary to ask the local CDC if there was any inventory. The reporter noted that there are still a number of vaccines against new strains that can be injected in various parts of the country.
Network transmission scheme (source: network)
The reporter noted that the payment time of the above plan was January 9, and it was stamped with the official seal of Beijing Sinovac Zhongwei Biotechnology Co., Ltd., which mentioned that at this stage, the company's new crown vaccine has all been discontinued and the company currently has no new crown vaccine product sales, and the company has decided to stop paying the new crown project performance salary to existing employees from January 2024.
Sinovac's new crown vaccine products (Source: Sinovac official website)
Beijing Sinovac Biotechnology Co., Ltd. is a subsidiary of Sinovac Holding Biotechnology Co., Ltd. At noon on January 10, the reporter called the product consultation hotline of Sinovac Holding Biotechnology Co., Ltd., and the staff confirmed that the company's Sinovac new crown vaccine has indeed been discontinued, and if you still need to inject the product, you have to ask the local CDC if there is any inventory. As for the authenticity of the "performance salary plan for the suspension of the new crown project" on the Internet, the other party said that it was not clear, and she was only responsible for product consultation.
The reporter noticed that some manufacturers had previously suspended the production of new crown vaccines.
In April last year, CanSino's "low-cost operation notice" was disseminated on the Internet. According to the content of the notice, it was decided to suspend production line production from April 4 for a period of 180 days. According to a report by Red Star News at the time, the staff of CanSino's patient answering hotline introduced that the new crown (vaccine) production line in Shanghai was temporarily suspended, and there was no problem at the headquarters. Now the demand for the new crown vaccine is not so large, so the production line of Shanghai CanSino new crown (vaccine) is temporarily suspended, and it will not affect other aspects.
Jimu News reporters learned that there are still a number of new crown vaccines that can be injected in various places. The reporter logged in to a vaccine injection appointment applet called "Xiaodou Miao" and found that Changsha also has three options: new crown pneumonia vaccine (Vero), new crown vaccine (adenovirus vector) and recombinant new crown vaccine (CHO). Among them, the new crown pneumonia vaccine (Vero) is one, and the details of the manufacturer are not remarked.
The reporter contacted a community health service center in Shanghai's Jing'an District, and the staff said that there was no Sinovac vaccine to be injected here, but there was another manufacturer of the new crown vaccine that could be injected. However, because the vaccine is not against the latest strain, citizens in need are advised to go to other community health service centers and choose XBB vaccination.
According to a previous report by Xinhua News Agency, the Beijing Center for Disease Control and Prevention said on December 11 that winter and spring are the seasons of high incidence of respiratory diseases, with a variety of pathogens circulating together, and the main circulating strains of the new coronavirus are XBB and its subclades. In order to cope with the infection situation this winter and next spring, Beijing has recently launched the implementation of new coronavirus vaccination with XBB variant antigen components for key groups such as the elderly.
According to the Daily Economic News, a number of XBB vaccines have been approved for emergency use in mainland China. In June 2023, Chengdu WestVac's recombinant trivalent novel coronavirus (XBB+BA.5+Delta variant) trimeric protein vaccine was included in emergency use within a certain range. In December, companies such as Shenzhou Cell, CanSino, and Livzon Group also successively issued announcements that the new crown vaccine was included in the emergency use.
(Source: Jimu News)